169Annual licence fees

#### 169 Annual licence fees 169 Annual licence fees > > (1) The holder of a licence to manufacture drugs of addiction must, on or before 30 September in each year following that in which the licence was issued, pay to the Secretary an annual licence fee of— > > > > > (a) $92, if the holder is a public institution, or > > > > > (b) $815, in any other case. > > > (2) The holder of a licence to supply drugs of addiction must, on or before 30 September in each year following that in which the licence was issued, pay to the Secretary an annual licence fee of— > > > > > (a) $21, if the holder is a charitable organisation, or > > > > > (b) $92, if the holder is a public institution (other than a charitable organisation), or > > > > > (c) $408, in any other case. > > **cl 169:** Am 2009 (490), cl 3 (3) (4); 2010 (485), cl 3 (2) (3); 2011 (394), cl 3 (1) (3) (4); 2012 (450), cl 3 (3) (4); 2013 (485) cl 3 (2) (3); 2014 (534), cl 3 (2) (4) (5); 2015 (305), cl 3 (2) (4)–(6); 2016 (286), cl 3 (2) (4) (5); 2017 (265), cl 3 (2) (4) (5); 2018 (232), cl 3 (2) (4)–(6); 2019 (206), cl 3 (2) (4) (5); 2020 (412), cl 3(2)(4)(5); 2021 (385), Sch 3\[7\] \[8\]; 2022 (445), Sch 3\[11\]–\[14\]; 2023 (499), Sch 3\[2\] \[4\]–\[6\]; 2025 (605), Sch 1\[2\] \[4\]–\[6\].